Hb Oslo [β42(CD1)Phe→Ile; HBB: c.127T>A]: A Novel Unstable Hemoglobin Variant Found in a Norwegian Patient. (4th March 2018)

• Record Type: Journal Article
• Authors: Grimholt, Runa M.; Vestli, Anne; Urdal, Petter; Bechensteen, Anne Grete; Fjeld, Bente; Dalhus, Bjørn; Klingenberg, Olav
• Is Part Of: Hemoglobin. Volume 42:Number 2(2018)
• Page Start: 78
• Page End: 83
• Publication Date: 2018-03-04
• Subjects: β-Globin gene -- hemoglobinopathy -- hemolysis -- hemolytic anemia -- unstable hemoglobin (Hb); Hemoglobinopathy -- Periodicals; Hemoglobin -- Periodicals; Hematology -- Periodicals; Thalassemia -- Periodicals; Blood -- Diseases -- Periodicals; 612.1111
• DOI: 10.1080/03630269.2018.1468773
• Languages: English
• ISSNs: 0363-0269

Abstract

Abstract: Unstable hemoglobin (Hb) variants are the result of sequence variants in the globin genes causing precipitation of Hb molecules in red blood cells (RBCs). Intracellular inclusions derived from the unstable Hb reduce the life-span of the red cells and may cause hemolytic anemia. Here we describe a patient with a history of hemolytic anemia and low oxygen saturation. She was found to be carrier of a novel unstable Hb variant, Hb Oslo [β42(CD1)Phe→Ile ( T TT> A TT), HBB : c.127T>A] located in the heme pocket of the β-globin chain. Three-dimensional modeling suggested that isoleucine at position 42 creates weaker interactions with distal histidine and with the heme itself, which may lead to altered stability and decreased oxygen affinity. At steady state, the patient was in good clinical condition with a Hb concentration of 8.0–9.0 g/dL. During virus infections, the Hb concentration fell and on six occasions during 4 years, the patient needed a blood transfusion.